What is the management of a bleeding fibrous tumor in the lung?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of a Bleeding Fibrous Tumor in the Lung

For bleeding fibrous tumors in the lung, immediate airway protection with a large-diameter single-lumen endotracheal tube followed by bronchoscopy for diagnosis and intervention is the recommended first-line management approach. 1

Initial Management of Hemoptysis

Immediate Interventions

  • Secure the airway with a large-diameter single-lumen endotracheal tube to facilitate bronchoscopic suctioning and removal of clots 1
  • Position patient with the bleeding side down if known 1
  • Perform urgent bronchoscopy for both diagnostic and therapeutic purposes 2, 1
  • Assess vital signs, oxygen saturation, respiratory status, complete blood count, coagulation studies, and renal function 1

Bronchoscopic Management

  • Identify the anatomic site and side of bleeding, nature of the bleeding source, severity of bleeding, and therapeutic feasibility 2

  • For visible central airway lesions, employ endobronchial management options:

    • Bronchoscopic tamponade (wedging technique)
    • Cold saline lavage
    • Instillation of vasoconstrictors (epinephrine)
    • Oxidized regenerated cellulose mesh (98% success rate) 2, 1
    • Argon plasma coagulation (100% control rate at 3 months)
    • Nd:YAG laser photocoagulation (60% response rate)
    • Electrocautery 2, 1
  • For persistent bleeding despite bronchoscopic interventions, consider bronchial blockade balloons for 24-48 hours 2

Definitive Management

Surgical Approach

  • Complete en bloc surgical resection is the preferred treatment for solitary fibrous tumors of the pleura (SFTP), both benign and malignant 3
  • For pedunculated tumors attached to visceral pleura, perform wedge resection of lung 3
  • For sessile tumors arising on the lung, perform larger lung resection 3
  • For sessile tumors on the chest wall, perform wide local excision, often with chest wall resection due to their propensity for local recurrence 3

Interventional Radiology

  • If bronchoscopic measures are unsuccessful, consider bronchial artery embolization to temporize the bleeding 2, 1
  • Embolization can be performed for active bleeding, is less invasive, and does not require general anesthesia 2

Radiation Therapy

  • For distal or parenchymal lesions not amenable to bronchoscopic intervention, external beam radiotherapy is recommended 2
  • EBRT has shown symptom relief rates of 81-86% for hemoptysis due to lung tumors 1

Special Considerations

Monitoring and Follow-up

  • Close follow-up is essential as fibrous tumors can grow rapidly and aggressively 4
  • Long-term follow-up for more than 10 years after surgery is necessary, particularly for tumors with areas of hypercellularity 5
  • MIB-1 index can help identify malignant characteristics of recurrent tumors 5

Prognosis

  • Benign SFTP has a high cure rate with an 8% local recurrence rate that is usually amenable to curative re-excision 3
  • Malignant SFTP, especially the sessile type, has a 63% recurrence rate even with complete resection 3
  • Overall long-term cure rate for all patients is 88-92% 3

Pitfalls to Avoid

  • Delaying airway protection can lead to asphyxiation and increased mortality 1
  • Underestimating the severity of hemoptysis can lead to increased morbidity and mortality 1
  • Delaying bronchoscopy in massive hemoptysis increases morbidity and mortality 1
  • Failing to coordinate care with a multidisciplinary approach involving pulmonology, interventional radiology, and thoracic surgery can lead to poor outcomes 1

Thorough exploration of the pleural cavity before tumor resection is mandatory to exclude any pleural involvement that may not be radiologically apparent 6.

References

Guideline

Management of Hemoptysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Solitary fibrous tumor of the pleura.

Cancer control : journal of the Moffitt Cancer Center, 2006

Research

Malignant solitary fibrous tumor of pleura accompanied with first symptoms of chest pain and hemoptysis: a case report.

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2012

Research

Giant solitary fibrous tumor of the pleura causing respiratory insufficiency: report of 3 cases.

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.